We help women's health companies enter Asia with proof their product will work.

Before you commit to a launch, we test your product with real women, clinicians and laboratories in Asia, and give you a clear decision: launch, adapt or stop.

Book an introductory call
  1. 01

    Real-world evidence

    Tested in the market itself.

  2. 02

    Independent advice

    No products of our own.

  3. 03

    A clear decision

    Launch, adapt or stop.

The problem

Not all women are the same. Not all markets are the same.

MeasureAsiaUS and EuropeWhat changes for your product
Average age of menopause3,27,28 46India ~51 Target age and positioning
Persistent hot flashes4 Less commonChinese women More common Symptom focus and claims
BMI at the same type 2 diabetes risk1 23.9South Asian adults 30White adults Risk thresholds and algorithms
Tampons, share of the feminine hygiene market29 2.9%China 26.7%United States Product format
Hormone patches17,22 58%of Thai women had skin reactions EstablishedRising demand in the UK Formulation and adhesion

See the full evidence, with three case studies.

Read the evidence brief
Our approach

Reports describe the market. We test your product in it.

What you getDesk
research
A local
distributor
Sankalpa
Market size, competitors and pricing✓Partly✓
Tested with real women in local conditions✕✕✓
Laboratory and clinical evaluation✕✕✓
Independent of who sells the product✓✕✓
Introductions to vetted partners✕Own network✓
A clear decision: launch, adapt or stop✕✕✓
What you get

One assessment. A clear answer.

For therapeutics, diagnostics, medical devices, consumer health and digital health.

Part 1

Market fit research

Interviews with the clinicians, buyers and women who will decide your success.

Part 2

Real-world evaluation

Your product tested with patients and in local conditions.

Part 3

Regulatory and commercial path

The route, timeline, pricing and first market segment.

Part 4

Decision and partners

A scored recommendation, and introductions to the partners you need.

GoConditional goNo-go
The opportunity

Most of the world's women live in Asia. Few products are proven for them.

58.6%

of the world's population lives in Asia24

~400m

women aged 45 and over in India10

~16%

annual growth of the Asia-Pacific femtech market9

$1tn

a year in global gains by 2040 from closing the women's health gap26

Our name
Sankalpa.
सङ्कल्प · suhn-KUHL-puh · Sanskrit for a firm intention

Our intention: women in Asia should get products that are proven to work for them.

Questions

Frequently asked questions

Which products do you assess?

Any women's health product: therapeutics, diagnostics, medical devices, consumer health and digital health. Products are usually on the market, or close to it, in their home market.

Which markets do you cover?

India, and other countries in Asia on request.

Do you handle regulatory approval?

We map the regulatory pathway, timeline and requirements in every assessment, and can coordinate specialist support. Approval itself is granted by the national regulator.

How is my confidential information protected?

Information is shared with partners only as far as testing requires, under confidentiality agreements that bar use for competing products. Results are shared only with your consent.

What happens after a positive recommendation?

We introduce you to vetted manufacturing and distribution partners and to investors, matched to your product.

Thinking of launching in Asia? Find out before you launch.

Tell us about your product. We reply within two working days, or write to info@sankalpapartners.com.

We use your details only to reply. Privacy